Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHA:688566)
China flag China · Delayed Price · Currency is CNY
27.96
-0.08 (-0.29%)
Apr 29, 2026, 3:00 PM CST

SHA:688566 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
990.68966.07896.53860.93654.73509.69
Revenue Growth (YoY)
9.58%7.76%4.13%31.49%28.46%-9.94%
Cost of Revenue
103.09101.8295.2697.1876.1762.12
Gross Profit
887.6864.25801.28763.76578.56447.57
Selling, General & Admin
591.92563.08458.54459.86361.56304.65
Research & Development
42.4640.738.6555.7755.1829.28
Other Operating Expenses
12.9511.7712.9810.479.249.1
Operating Expenses
647.33615.54512.43533.31426.71341.26
Operating Income
240.26248.7288.85230.44151.85106.32
Interest Expense
---0.13-0.11-0.38-
Interest & Investment Income
--5.412.0217.7721.64
Other Non Operating Income (Expenses)
56.6855.08-0.11-0.14-0.07-0.11
EBT Excluding Unusual Items
296.94303.78294.01242.22169.18127.85
Gain (Loss) on Sale of Investments
-2.72-2.64-1.05-1.9--
Gain (Loss) on Sale of Assets
-----0.01-
Asset Writedown
-0.01-0.01-42.24---
Other Unusual Items
--2.657.165.374.71
Pretax Income
294.21301.13253.36247.48174.53132.56
Income Tax Expense
41.7140.1434.3928.7120.2718.22
Earnings From Continuing Operations
252.5261218.98218.77154.26114.35
Minority Interest in Earnings
1.570.610.350.320.40.55
Net Income
254.07261.61219.33219.09154.67114.9
Net Income to Common
254.07261.61219.33219.09154.67114.9
Net Income Growth
17.44%19.28%0.11%41.65%34.61%-11.42%
Shares Outstanding (Basic)
200200194187186188
Shares Outstanding (Diluted)
200200194187186188
Shares Change (YoY)
1.74%2.89%3.65%0.49%-1.07%11.81%
EPS (Basic)
1.271.311.131.170.830.61
EPS (Diluted)
1.271.311.131.170.830.61
EPS Growth
15.43%15.93%-3.42%40.96%36.07%-20.78%
Free Cash Flow
70.99133.7140.76-197.87-141.9866.77
Free Cash Flow Per Share
0.350.670.21-1.06-0.760.35
Dividend Per Share
--0.780-0.4800.480
Gross Margin
89.59%89.46%89.38%88.71%88.37%87.81%
Operating Margin
24.25%25.74%32.22%26.77%23.19%20.86%
Profit Margin
25.65%27.08%24.46%25.45%23.62%22.54%
Free Cash Flow Margin
7.17%13.84%4.55%-22.98%-21.68%13.10%
EBITDA
259.82266.47299.45241.65164.6119.3
EBITDA Margin
26.23%27.58%33.40%28.07%25.14%23.41%
D&A For EBITDA
19.5617.7710.611.212.7512.98
EBIT
240.26248.7288.85230.44151.85106.32
EBIT Margin
24.25%25.74%32.22%26.77%23.19%20.86%
Effective Tax Rate
14.18%13.33%13.57%11.60%11.62%13.74%
Revenue as Reported
--896.53860.93654.73509.69
Advertising Expenses
----153.2121.29
Source: S&P Global Market Intelligence. Standard template. Financial Sources.